Predictive value of frontal alpha asymmetry in evaluating prognosis of pediatric status epilepticus based on EEG

Liping Xie1,2, Tao Yu1,2, Jielan Zhou1,2

  • 1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu City, Sichuan Province, China.

Medicine
|May 19, 2026
PubMed

Insights

Frontal alpha asymmetry (FAA) measured by electroencephalogram can predict outcomes in pediatric status epilepticus (SE). Higher FAA levels indicate a better prognosis, aiding clinical decisions for children with SE.

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Biomarkers

Background:

  • Pediatric status epilepticus (SE) presents significant prognostic challenges.
  • Identifying reliable predictors for SE outcomes is crucial for timely clinical intervention.
  • Frontal alpha asymmetry (FAA) is a potential electroencephalogram (EEG)-based biomarker.

Purpose of the Study:

  • To evaluate the predictive capability of frontal alpha asymmetry (FAA) for the prognosis of pediatric status epilepticus (SE).
  • To identify factors influencing the prognosis of pediatric SE.
  • To establish the diagnostic accuracy of FAA in predicting SE outcomes.

Main Methods:

  • Retrospective analysis of 177 pediatric SE patients.
  • Comparison of clinical outcomes between good and poor prognosis groups.
  • Univariate, binary logistic regression, and receiver operating characteristic (ROC) curve analyses were performed.

Main Results:

  • Significant differences in SE onset, seizure cessation time, and FAA were observed between prognosis groups (P < .05).
  • FAA and time to seizure cessation were independent predictors of pediatric SE prognosis (P < .05).
  • ROC analysis showed an AUC of 0.805 for FAA, with 90.20% sensitivity and 52.38% specificity.

Conclusions:

  • Frontal alpha asymmetry (FAA) demonstrates significant value in predicting the prognosis of pediatric status epilepticus.
  • An optimal FAA cutoff value of 88.96 (×10-3 μV) can differentiate between good and poor prognoses.
  • Higher FAA levels correlate with favorable clinical outcomes and lower post-treatment biomarker levels.

Related Concept Videos